MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$15.00 -0.14 (-0.92%)
Open Price: 15.35
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients